The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients

Canine cancer rates are similar to humans, though the therapeutic options might be limited. Inducing a patient’s own immune system to have an anti-tumor response is an attractive approach to cancer therapy. In this safety study, autologous tumor vaccines produced specifically for each canine patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Weir, Chris, Oksa, Annika, Millar, Jennifer, Alexander, Miles, Kynoch, Nicola, Walton-Weitz, Zoe, Mackenzie-Wood, Peter, Tam, Felicia, Richards, Hope, Naylor, Richard, Cheng, Katrina, Bennett, Peter, Petrovsky, Nikolai, Allavena, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313922/
https://www.ncbi.nlm.nih.gov/pubmed/30322015
http://dx.doi.org/10.3390/vetsci5040087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313922/
https://www.ncbi.nlm.nih.gov/pubmed/30322015
http://dx.doi.org/10.3390/vetsci5040087

Ejemplares similares